A biotech executive committed insider trading when he bet on a competitor's stock, believing the shares would rise when news about his own company hit the market, a jury found.
Apr 7, 2024 11:06 PM
A biotech executive committed insider trading when he bet on a competitor’s stock, believing the shares would rise when news about his own company hit the market, a jury found.
